NOTCH1 and hepatocellular carcinoma: In summary, our results demonstrate that HBx can act as an oncogenic factor to promote the progression of HCC by binding to NICD to activate the Notch signaling pathway, which may provide a new clue for the potential role of Notch signaling in the HBx-associated human liver carcinoma.